cyproterone acetate has been researched along with Chromosome-Defective Micronuclei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, ME; Davis, KJ; Ding, W; Lyn-Cook, LE; Manjanatha, MG; Pearce, MG; White, GA | 1 |
| Allavena, A; Brambilla, G; De Pascalis, CR; Ghia, M; Martelli, A; Mereto, E; Orsi, P | 1 |
2 other study(ies) available for cyproterone acetate and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Sex-specific dose-response analysis of genotoxicity in cyproterone acetate-treated F344 rats.
Topics: Animals; Comet Assay; Cyproterone Acetate; DNA Damage; Dose-Response Relationship, Drug; Female; Humans; Liver; Male; Mammary Glands, Human; Micronuclei, Chromosome-Defective; Micronucleus Tests; Olive Oil; Oxidation-Reduction; Plant Oils; Rats; Rats, Inbred F344; Reticulocytes; Sex Characteristics; Testis | 2014 |
Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins.
Topics: Allylestrenol; Animals; Biotransformation; Carcinogens; Cyproterone Acetate; Dydrogesterone; Female; gamma-Glutamyltransferase; Liver; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Norethindrone; Progesterone; Progesterone Congeners; Rats; Rats, Sprague-Dawley | 1998 |